Is Platelet Aggregation a Useful Investigation in Assessing the Risk of Thrombosis in Patients With JAK-Positive Chronic Myeloproliferative Disorders? Brief Report: A Study on 14 P... von Popov, V.M., Vladareanu, A.M., Bumbea, H., Casleanu, D., Ilea, A., Onisai, M., Nicolescu, A., Marinescu, C., Ciufu, C., Voican, I., Begu, M., Vintilescu, A.M., Dobrea, C., Kovacs, E., Savopol, T.

Volltext

356 Pulmonary embolism combined with heterozygous carrier for factor V Leiden as initial clinical presentation in chronic myelomonocytic leukaemia von Gaman, M, Vladareanu, A.M, Cisleanu, D, Bumbea, H, Begu, M, Vintilescu, A, Cazaceanu, O, Baluta, C, Onisai, M, Voican, I, Nicolescu, A, Dobrea, C, Ilea, A, Bogdan, M

Volltext

377 Maintenance of normal serum ferritin in a patient with myelodysplastic/myeloproliferative disease-unclassifiable using deferasirox. A case report von Gaman, M, Vladareanu, A.M, Voican, I, Cisleanu, D, Bumbea, H, Onisai, M, Alexe, A, Begu, M, Vintilescu, A, Cazaceanu, O, Baluta, C, Ilea, A, Dobrea, C

Volltext

365 Low risk MDS – presenting as lead poisoning – with rapid transformation to acute leukemia – case report von Cazaceanu, O, Baluta, C, Vladareanu, A.M, Begu, M, Bumbea, H, Vintilescu, A, Barsan, L, Vasile, D, Dobrea, C, Onisai, M, Nicolescu, A

Volltext